We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Danaher Corporation | NYSE:DHR | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.96 | 0.36% | 265.80 | 265.94 | 263.18 | 265.17 | 3,187,620 | 01:00:00 |
From May 2023 to May 2024
By Will Feuer
Danaher expects a key sales figure to fall in the third quarter and lowered its full-year forecast.
The health-care and laboratory-supply company expects third-quarter adjusted base business core sales, which strips out sales of products related to Covid-19 as well as currency fluctuations and other noisy factors, to fall by a low-single digit percentage from a year ago.
For the full year, Danaher expects that figure to be up by a low-single digit percentage. That is down from guidance offered in April for full-year adjusted base business core sales to be up by a mid-single digit percentage.
In the second quarter, adjusted base business core sales rose by 2%, even as non-adjusted sales fell by 7.5%.
Chief Executive Rainer Blair said the company faces a "more dynamic operating environment."
Shares fell 3.9% to $248.00 in premarket trading.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
July 25, 2023 06:38 ET (10:38 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Danaher Chart |
1 Month Danaher Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
